Phi Finney McDonald is broadly regarded as one of Australia’s pre-eminent securities class action law firms.

Shareholders deserve honesty, accountability, and transparency from the companies in which they invest. Companies that mislead the market harm their investors and the broader economy. Investors who suffer loss or damage from securities fraud and misconduct are entitled to redress. The firm’s repeat clients include some of the largest and most influential pension schemes, private investors, sovereign wealth funds, and investment platforms across Europe, the Middle East, North America, and the Asia Pacific.

Investor claims involve complex financial issues and require specialist expertise. We provide clients with the experience and endurance to take on the largest companies and most powerful institutions. We have strong and enduring relationships with litigation funders, developed over many years, that enable us to obtain the funding our clients need to fight cases confidently from a position of strength.

Phi Finney McDonald’s founders previously ran the class actions practice at a large plaintiff law firm. Together they have over 30 years of shareholder class actions experience and have recovered over half a billion dollars for investors. They have prosecuted shareholder class actions against companies including Estia, BHP, UGL, Westpac, Commonwealth Bank, GetSwift, Centro, GPT Group, Sigma Pharmaceuticals, Nufarm, Downer EDI, ION, Billabong and Newcrest.

The firm has received judicial recognition for bringing innovation to the Australian class actions and litigation funding markets. The firm won the first two ‘beauty parades’ in Australian class action history and was awarded carriage of the GetSwift and BHP class actions by the Federal Court of Australia. PFM retained sole carriage of the Westpac shareholder class action after a competing claim was discontinued by consent.

Phi Finney McDonald’s objective is to create and implement novel funding structures that increase our clients’ net returns; ensure that the plaintiff’s own costs and adverse costs indemnities are well-supported; and allow institutional investors to exercise autonomy of choice, to influence carriage decisions (whether passively or actively), and to use their financial strength to produce better commercial returns for their fiduciaries.